The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with Type 2 diabetes mellitus

Diabetic Medicine

Volumn 16, Issue 12, 1999, Pages 1036-1039

  Song, Ki Ho ^a,b   Ahn, Y B ^a   Yoon, K H ^a   Cha, B Y ^a   Lee, K W ^a   Son, H Y ^a   Kang, S K ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Glycaemic control; Lipoprotein(a); Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE HOMEOSTASIS; HEMOGLOBIN DETERMINATION; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPOPROTEIN(A); MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0033392659     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00183.x     Document Type: Article

References (19)

1. 1 Kannel WB, McGee DC. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979; 59: 8-13.
2. 2 Utermann G. The mysteries of lipoprotein (a). Science 1989; 246: 904-910.
3. 3 Scanu AM, Lawn RM, Berg K. Lipoprotein (a) and atherosclerosis. Ann Intern Med 1991; 115: 209-218.
4. 4 Hiraga T, Kobayashi T, Okubo M, Nakanishi K, Sugimoto T, Ohashi Y et al. Prospective study of lipoprotein (a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 1995; 18: 241-244.
5. 5 Haffner SM, Morales PA, Stern MP, Gruber MK. Lp (a) concentrations in NIDDM. Diabetes 1992; 41: 1267-1272.
6. 6 Chang C-J, Kao J-T, Wu T-J, Lu F-H, Tai T-Y. Serum lipids and lipoprotein (a) concentrations in Chinese NIDDM patients. Diabetes Care 1995; 18: 1191-1194.
7. 7 Imperatore G, Rivellese A, Galasso R, Celentano E, Iovine C, Ferrara A et al. Lipoprotein (a) concentrations in non-insulin-dependent diabetes mellitus and borderline hyperglycemia: a population-based study. Metabolism 1995; 44: 1293-1297.
8. 8 Haffner SM, Tuttle KR, Rainwater DL. Lack of change of lipoprotein (a) concentration with improved glycaemic control in subjects with type II diabetes. Metabolism 1992; 41: 116-120.
9. 9 Ritter MM, Richter WO, Lyko K, Schwandt P. Lp (a) serum concentration and metabolic control (Letter). Diabetes Care 1992; 15: 1441-1442.
10. 10 Wolffenbuttel BH, Leurs PB, Sels JP, Rondas-Colbers GJWM, Menheere PPCA, Nieuwenhuijzen AC. Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein (a) levels. Diabet Med 1993; 10: 427-430.
11. 11 Kikuchi T, Onuma T, Shimura M, Tsutsui M, Boku A, Matsui J et al. Different change in lipoprotein (a) levels from lipid levels of other lipoproteins with improved glycaemic control in patients with NIDDM. Diabetes Care 1994; 17: 1059-1061.
12. 12 Caixas A, Perez A, Ordonez-Llanos J, Bonet R, Rigla M, Castellvi A et al. Lack of change of lipoprotein (a) levels by the optimization of glycaemic control with insulin therapy in NIDDM patients. Diabetes Care 1997; 20: 1459-1461.
13. 13 Purnell JQ, Marcovina SM, Hokanson JE, Kennedy H, Cleary PA, Steffes MW et al. Levels of lipoprotein (a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. results from follow-up in the Diabetes Control and Complication Trial. Diabetes 1995; 44: 1218-1226.
14. 14 Hother-Nielsen O, Faber O, Sorensen NS, Beck-Nielsen H. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 1988; 11: 531-537.
15. 15 Son HY, Song KH, Han JH, Lee JM, Yoo SJ, Hon HS et al. Changes of lipoprotein (a) concentrations in non-insulin-dependent diabetic patients without overt proteinuria after short-term glycaemic control (Abstract). Diabetologia 1994; 37: A144.
16. 16 Jenkins AJ, Steele JS, Janus ED, Santamaria JD, Best JD. Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1992; 35: 1055-1059.
17. 17 Hernandez C, Simo R, Chacon R, Segarra A, Lopez D, Mesa J. Relationship between lipoprotein (a) phenotypes and albumin excretion rate in non-insulin-dependent diabetes mellitus: protective effect of 'null' phenotype? Eur J Clin Invest 1997; 27: 497-502.
18. 18 Nakata H, Horita K, Eto M. Alteration of lipoprotein (a) concentration with glycaemic control in non-insulin-dependent diabetic subjects without diabetic complications. Metabolism 1993; 42: 1323-1326.
19. 19 United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.